 |
 |
| |
Polio Plus
|
| |
| 21-Apr-06 |
UPDATE: March 2006 |
|
| |
International PolioPlus Committee |
| |
Statements
on Current Facts and Figures Relative to Polio Eradication
and the Role of Rotary International in the Global Effort
|
| |
For the sake of clarity and consistency in all Rotary publications
and information, the International PolioPlus Committee has
adopted the following set of frequently reported statements,
statistics, and terms concerning the PolioPlus Program and
the global polio eradication effort, and encourages all members
in the global partnership for polio eradication to adopt similarly
consistent statements and figures. The Committee has also
requested a wide dissemination within Rotary for these statements.
The Committee reviews these statements at each meeting, to
ensure that they remain current and appropriate
|
| |
| 1. A statement on the goal of
the PolioPlus program: |
| |
The goal of
the PolioPlus program is the global certification
of polio eradication. By eradication, WHO, the Global
Commission on Certification, and Rotary mean the interruption
of the transmission of the wild poliovirus.”
|
| 2. A statement on
Rotary International's contribution to the polio eradication
effort: |
| |
“By the
time the world is certified polio-free, Rotary’s
contributions to the global polio eradication effort
be nearly US$650 million. In addition, millions of
dollars of 'in-kind' and personal contributions have
been made by and through local Rotary clubs and districts
for polio eradication activities. Of even greater
significance has been the huge volunteer army mobilized
by Rotary International. Hundreds of thousands of
volunteers at the local level are providing support
at clinics or mobilizing their communities for immunization
or polio eradication activities. More than one million
Rotarians worldwide have contributed toward the success
of the polio eradication effort to date."
|
| 3. A statement on the number of
nations benefiting from PolioPlus grants:
|
| |
“To date, 122 nations around
the world have benefited from PolioPlus grants for polio
immunization and eradication efforts.” |
| 4. A statement on the number of
polio cases prevented annually through immunization: |
| |
“From
the launch of the global initiative in 1988, 5 million
people, mainly in the developing world, who
would otherwise have been paralyzed, will be walking
because they have been immunized against polio. More
than 500,000 cases of polio are now prevented each
year by the efforts of governments and the partnership
of the World Health Organization (WHO), Rotary International,
the United Nations Children’s Fund (UNICEF),
the United States Centers for Disease Control and
Prevention (CDC), and the overseas development agencies
of donor nations.”
|
| 5. Statements on the number of
children immunized against polio: |
| |
a.
Since 1985, when Rotary implemented the PolioPlus
program:
"As a result of the efforts of Rotary International
and its Foundation and those of our partners, more
than two billion children have received oral polio
vaccine."
b. immunizations in 2005:
“As part of the global polio eradication effort
in 2005, over 390 million children were vaccinated
in 47 countries using nearly two billion doses of
oral polio vaccine.”
|
| 6. A statement on the percentage
of the world’s children that live in polio-free
countries: |
| |
“In 1988,
10% of the world’s children lived in polio-free
countries; as of 1 July 2005, over 70% are living
in polio-free countries.
|
| 7. A statement on the reduction
of cases of polio: |
| |
“The
number of cases of polio has declined by 99% since
Rotary launched the PolioPlus program.”
|
8. A statement
on the cost of vaccine per child: |
| |
“A child
can be protected against polio for as little as US$
.60 worth of vaccine.”
|
| 9. A statement on the number of
polio endemic countries: |
| |
“Since
Rotary began its PolioPlus Program, the number of
countries which continue to be polio endemic has declined
from over 125 countries in 1985 to 4 countries at
the start of 2006. The number of polio cases has declined
by more than 99% since 1985.
|
10. A statement
on the number of countries that are polio-free and
the number of
people who live in countries, territories, and areas
that have been
certified polio-free by independent commissions: |
| |
“Two
hundred and ten (210) countries, territories and areas
are now polio-free, and 134 of these have been certified
polio-free by independent commissions. In June 2002,
the WHO European Region was certified polio-free,
joining the WHO Regions of the Americas and the Western
Pacific. More than three billion people, half the
world’s population lives in the 134 countries,
territories and areas that are now certified polio-free.”
|
11. Statements
on polio in India, Nigeria and Niger: |
| |
At the start
of 2006, transmission of indigenous poliovirus had
been interrupted in all but four countries (Nigeria,
India, Pakistan, and Afghanistan). However, between
early 2003 and mid-2005, poliovirus spread to 21 previously
polio-free countries. As of January 2006, only 8 of
these countries were still reporting cases (Indonesia,
Yemen, Somalia, Ethiopia, Angola, Nepal, Niger and
Chad).
Strong progress in Asia: Intensified polio campaigns
in India, Pakistan and Afghanistan resulted in strong
progress especially in the traditional reservoirs
of India and Pakistan. Cases were nearly halved in
2004 with 193 reported compared to 336 in 2003. India
is making particular progress, with only 63 cases
reported in 2005 (as at 10 January 2006), and transmission
confined to several key districts.
Progress leads to introduction of new polio
vaccine: Progress in Egypt and India in eliminating
poliovirus types 2 and 3 prompted the rapid development
of monovalent oral polio vaccine type 1 (mOPV1) to
interrupt the final chains of transmission in these
countries. mOPV1 is more efficient at boosting immunity
against poliovirus type 1, than trivalent OPV (which
works against all three polio strains). mOPV1 is now
being used in India, Egypt and Pakistan, and in response
to the outbreaks in Yemen, Indonesia, Angola, Eritrea,
Ethiopia, Somalia and Sudan, and its use is expected
to be further expanded in 2006.
To more rapidly interrupt the final strains of type
3 transmission in India, monovalent OPV type 3 (mOPV3)
was used for the first time in selected key districts
in December 2005.
Africa - polio eradication back on track:
Polio eradication is back on track in Africa following
the resumption of immunizations in Kano, Nigeria (which
had been suspended due to unfounded concerns as to
the safety of the polio vaccine). In response to the
ongoing outbreak, the African Union (AU) conceived
and conducted synchronized immunization campaigns
in more than 25 countries. Strong improvements were
documented in northern Nigeria, where independent
monitoring suggested the number of 'missed' children
during campaigns was reduced from 50% in 2004, to
15% in 2005.
Sporadic outbreaks not the major risk to global
eradication effort: The sporadic outbreaks
of polio in previously polio-free countries, due to
imported virus (e.g. Indonesia) do not represent the
major risk to the global eradication effort. Historical
evidence shows that the rapid implementation of high-quality
immunization activities can rapidly stop such sporadic
outbreaks.
|
12. A statement
on the contribution of Rotary’s advocacy efforts:
|
| |
Public Advocacy
Efforts: “In 1995, Rotary International launched
a task force to advocate the cause of polio eradication
to donor governments. This task force, later to be
part of the Polio Advocacy Group, with additional
partners, has resulted to date in more than US$1.7
billion in polio-specific grants from the public sector.
These advocacy efforts are ongoing and will be continued
as necessary.”
|
13. Definitions
of the terms Partners, Spearheading Partners, Coalitions
and Donors are
outlined below: |
| |
“When
used as generic terms to refer to organizations who
are also sharing in work and funds to eradicate polio,
either partners or partnerships is preferred. Generally,
coalition should be used to describe a specific group.
Donor is a term to describe an entity which is providing
funds to eradicate polio and should be limited to
those whose primary or exclusive role is in providing
funds. “Donor” should be avoided in describing
Rotary International or its Foundation.”
“Where partners is used to delineate specific
organizations engaged in global eradication of polio
spearheading partners refers to the World Health Organization
(WHO), Rotary International (RI), the U.S. Centers
for Disease Control and Prevention (CDC), and the
United Nations Children’s Fund (UNICEF).”
“Rotary is engaged in one specific coalition;
that is the coalition to advocate for increased contributions
by the U.S. Government to global polio eradication.
The coalition includes The Rotary Foundation of R.I.,
The United Nations Foundation, The Task Force for
Child Survival and Development, the U.S. Fund for
UNICEF, the American Academy of Pediatrics and the
March of Dimes Birth Defects Foundation. Rotary is
the leader.”
“Rotary is the leading non-governmental contributor.
Whenever possible, most of the polio eradication costs
are borne by the polio-endemic countries themselves.
However, as the battle against polio is taken to the
poorest, least-developed nations on earth, and those
in the midst of civil conflict, up to 100 percent
of the NID and other polio eradication costs must
be met by external donor sources.”
“Polio-specific contributions have been made
by the following governments: Andorra, Australia,
Austria, Belgium, Canada, Denmark, Finland, France,
Germany, Iceland, Ireland, Italy, Japan, Luxembourg,
Malaysia, Monaco, the Netherlands, New Zealand, Norway,
Oman, Portugal, Qatar, Republic of Korea, the Russian
Federation, Saudi Arabia, Spain, Sweden, Switzerland,
Taiwan, Turkey, the United Arab Emirates, the United
Kingdom and the United States of America.”
|
15. A statement
on the cessation of polio immunization: |
| |
"After
interruption of wild poliovirus transmission, appropriate
containment of poliovirus stocks, and establishment
of sufficient polio vaccine stockpiles, immunization
with routine OPV will be stopped, resulting in substantial
financial savings (note: the magnitude of these savings
will depend on national decisions on the introduction
of IPV). This stoppage could be as early as three
years following the global interruption of wild poliovirus
transmission.”
|
| 16. A statement on estimated annual
global savings after cessation of immunization: |
| |
“Once
polio has been eradicated, the world will reap substantial
financial, as well as humanitarian, dividends due
to foregone polio treatment and rehabilitation costs.
Depending on national decisions on the future use
of polio vaccines, these savings could exceed US$1
billion per year.”
|
17. A statement
on the annual cost of immunization of U.S. children
against
polio: |
| |
“The
United States Centers for Disease Control and Prevention
(CDC) estimates that more than US$350 million per
year is spent on immunizing U.S. children against
polio.”
|
18. A statement
on type II wild poliovirus: |
| |
“Type
II wild poliovirus has not been found since October
1999, suggesting that transmission of one of the three
types of wild poliovirus may have been interrupted.”
|
19. A statement
on the importations of the poliovirus: |
| |
In 2003-05,
there were over 1,300 cases of paralytic polio following
importations of wild poliovirus into 21 previously
polio-free countries. Of these countries, eight continue
to have active transmission of imported polioviruses,
including the recently endemic country Niger, as well
as Indonesia, Yemen, Somalia, Ethiopia, Angola, Nepal
and Chad
|
20. A statement
on instances of vaccine-derived polio: |
| |
“Between
2004 and 2005 there were six episodes of circulating
vaccine-derived poliovirus resulting in approximately
60 polio cases in the Island of Hispaniola (which
includes Haiti and the Dominican Republic), Indonesia,
the Philippines, Madagascar, and China. The vaccine-derived
virus detected in Minnesota, USA in 2005 did not result
in any cases of paralytic polio.
|
21. A
statement on the Vitamin A distribution during polio
National Immunization
Days: |
| |
“Since
1998, the inclusion of Vitamin A supplements on NIDs
has averted an estimated 1.25 million childhood deaths.”
The Committee further requests that the General Secretary,
in official and public releases and statements, follow
the above expressions. Finally, the Committee requests
that all other RI and TRF officials and spokespersons,
and all organizations which report to the Committee,
adhere to the approved statements and observe the
recommended terminology. |
|
| |
|
| |
«
Back |
|
 |
|